Cargando…
Cutaneous Toxicities of Immune Checkpoint Inhibitors: The Role of the Dermatologist
The advent of immune checkpoint inhibition represents a paradigm shift in the treatment of an increasing number of cancers. However, the incredible therapeutic promise of immunotherapy brings with it the need to understand and manage its diverse array of potential adverse events. The skin is the mos...
Autores principales: | Tattersall, Ian William, Leventhal, Jonathan Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087048/ https://www.ncbi.nlm.nih.gov/pubmed/32226342 |
Ejemplares similares
-
Management of Immune Checkpoint Inhibitor Toxicities
por: Durrechou, Quentin, et al.
Publicado: (2020) -
Dermoscopy for Cutaneous Melanoma: Under the Eye of Both the Dermatologist and the Legal Doctor
por: Bolcato, Vittorio, et al.
Publicado: (2022) -
Management of pulmonary toxicity associated with immune checkpoint inhibitors
por: Delaunay, Myriam, et al.
Publicado: (2019) -
Management of advanced cutaneous T-cell lymphoma: role of the dermatologist in the multidisciplinary team
por: Poligone, B, et al.
Publicado: (2015) -
Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event
por: Pach, Jolanta, et al.
Publicado: (2021)